A defined microbiome therapeutic prevents recurrent Clostridioides difficile

被引：0
|
作者：
Khanna, Sahil [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 6卷 / 04期
关键词：
INFECTION; UPDATE;
D O I：
10.1016/S2468-1253(21)00011-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [31] SIGNIFICANT CORRELATIONS AMONG CLOSTRIDIOIDES DIFFICILE SPECIES AND PATHOGENIC BACTERIOPHAGES IN PATIENTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
    Verma, Sandeep
    Firnberg, Elad
    Vinayek, Rakesh
    Nair, Padmanabhan
    Dutta, Sudhir
    GASTROENTEROLOGY, 2022, 162 (07) : S1000 - S1000
  • [32] Therapeutic potential of miRNAs in Clostridioides difficile infection
    Monaghan, Tanya M.
    Polytarchou, Christos
    Kao, Dina
    Alexander, Cameron
    Gurnani, Pratik
    FUTURE MICROBIOLOGY, 2022, 17 (05) : 315 - 318
  • [33] Diagnostic and therapeutic management of Clostridioides difficile infection
    Zunigaa, Miguel angel Lopez
    Cabellob, Antonio Sanchez
    Ruza, Miguel angel Lopez
    MEDICINA CLINICA, 2025, 164 (03): : 136 - 142
  • [34] Unexpected Results From a Phase 2 Trial of a Microbiome Therapeutic for Clostridioides difficile Infection: Lessons for the Future
    Young, Vincent Bensan
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : 2141 - 2143
  • [35] Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)
    Minkoff, Nathan Zev
    Aslam, Scheherzade
    Medina, Melissa
    Tanner-Smith, Emily E.
    Zackular, Joseph P.
    Acra, Sari
    Nicholson, Maribeth R.
    Imdad, Aamer
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (04):
  • [36] Clostridioides difficile infections: Update and therapeutic guidelines
    Berrut, Gilles
    Baudron, Claire Roubaud
    Paccalin, Marc
    de Wazieres, Benoit
    Gavazzi, Gaetan
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DU VIEILLISSEMENT, 2024, 22 (03) : 316 - 324
  • [37] RAPID CONVERSION OF PRIMARY TO SECONDARY BILE ACIDS IN SUBJECTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) FOLLOWING SER-109, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC
    Bryant, Jessica A.
    Diao, Liyang
    O'Brien, Edward J.
    Ford, Christopher B.
    Litcofsky, Kevin D.
    Wortman, Jennifer R.
    Henn, Matthew R.
    GASTROENTEROLOGY, 2021, 160 (06) : S168 - S168
  • [38] Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial
    Cohen, Stuart H.
    Louie, Thomas J.
    Sims, Matthew
    Wang, Elaine E. L.
    Memisoglu, Asli
    McGovern, Barbara H.
    von Moltke, Lisa
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (20): : 2062 - 2064
  • [39] Functional profile of host microbiome indicates Clostridioides difficile infection
    Nzabarushimana, Etienne
    Tang, Haixu
    GUT MICROBES, 2022, 14 (01)
  • [40] Small Intestinal Microbiome Differs in Relationship to Clostridioides difficile Infection
    Schupack, Daniel A.
    Chen, Jun
    Lekatz, Heather
    Kashyap, Purna
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S648 - S648
12345